Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
about
Macrophage migration inhibitory factor involvement in breast cancer (Review)Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkersInvolvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.Sex-dependent treatment of chronic EAE with partial MHC class II constructs.HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancerTrichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responsesABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone.Thrombin induces macrophage migration inhibitory factor release and upregulation in urothelium: a possible contribution to bladder inflammation.The anti-metastatic nm23-1 gene is needed for the final step of mammary duct maturation of the mouse nipple.Spatiotemporal patterns of macrophage migration inhibitory factor (Mif) expression in the mouse placenta.Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109Association between macrophage migration inhibitory factor promoter region polymorphism (-173 G/C) and cancer: a meta-analysisMacrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumor metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblastsCD74 interferes with the expression of fas receptor on the surface of lymphoma cellsProfilin-1 overexpression in MDA-MB-231 breast cancer cells is associated with alterations in proteomics biomarkers of cell proliferation, survival, and motility as revealed by global proteomics analyses.Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells.MED29, a component of the mediator complex, possesses both oncogenic and tumor suppressive characteristics in pancreatic cancerHuman adipocytes stimulate invasion of breast cancer MCF-7 cells by secreting IGFBP-2Non-viral nanoparticle delivers small interfering RNA to macrophages in vitro and in vivo.Human umbilical cord matrix mesenchymal stem cells suppress the growth of breast cancer by expression of tumor suppressor genes.Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression.MIF and autophagy: a novel link beyond "eating"Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model.A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum.Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling.Secreted and O-GlcNAcylated MIF binds to the human EGF receptor and inhibits its activationExpression of MIF and c-erbB-2 in endometrial cancer.Role of MIF/CD74 signaling pathway in the development of pleural mesotheliomaMilatuzumab - a promising new immunotherapeutic agent.CD74: a new prognostic factor for patients with malignant pleural mesothelioma.Macrophage migration inhibitory factor (MIF): a promising biomarker.MIF: a key player in cutaneous biology and wound healing.CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease.Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine.Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities.Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment.Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome.Macrophage Migration Inhibitory Factor (MIF): Biological Activities and Relation with Cancer.Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases.Identification of differentially expressed inflammatory factors in Wilms tumors and their association with patient outcomes.
P2860
Q26786136-9CEBD251-404D-43AC-88FB-1F8ED2B1A57CQ27023385-7B58B90C-E2FB-4E4A-BEC5-A653D72C936DQ30435034-2A73C0D1-FB36-43AA-AD9B-D711FF72384EQ33645392-3883BD19-BB33-4A16-A0F4-B5A5BD176075Q33694931-FCCCD738-82DE-4AB9-ADA6-70FE21915795Q33730715-F68D0087-15B3-4F23-9AC3-980BDF58FF1DQ33739392-994BF3C0-82F9-447C-A3DF-99CA9FEEE348Q33786834-1FA07ABB-0D7B-4102-B29E-681E1AA9BDE6Q33872219-D56D5DA8-06B2-46DF-9738-717F4CEBBCEFQ34068281-9AAD7895-37A7-465D-8B70-2ED85BE00595Q34088459-2856A3BC-7F57-4393-BC21-CC2EDFFF318EQ34100932-35896365-6D60-4F67-8A14-1FD0FFD0F7A0Q34280104-5168A432-9E3E-4182-8AE9-D450E1F086D5Q34409837-A03E5ADB-C314-4247-B2EA-1C6EB1DFE9D5Q34617881-9DA0F2E7-8696-45BB-BE55-B90EF165EEA2Q34786543-80E56FC5-7BBB-4712-A1FD-724CFDD8F98DQ35054391-3FE365B9-4DA7-4F2D-9533-0EC9B04646B1Q35154695-4976DA05-3404-43C9-B6A7-2B70FC613B80Q35208236-947E14B5-784D-4B69-8588-E8F52280F21CQ35571688-A265B565-C7DA-4E08-854E-0DFAF7BD803AQ35760817-040D41EC-1BA1-4FC4-8152-3F8343EB1AAEQ36009197-4FD4684D-33AB-4D9B-8E9F-6EF897E54A6EQ36385260-A4BCCF10-6605-496C-8028-5DB8A3DCC9C3Q36396615-915334AC-26FC-4909-96E4-08D33599B4B4Q36413560-0C187BED-37CD-4C1E-A2D4-2C32186AAD5AQ36672321-6DFD09A7-732B-46D6-8A94-BD66C99630DEQ36817369-F2669ED3-0144-4A58-B241-D8E582019146Q36998296-8EC68639-B929-4A77-BEEF-F138B79BE050Q37646791-55D687C5-4CAE-4D57-8ECF-4D2C69C8A06DQ37711647-A4653DCB-760D-4A86-AB0F-3142D7AAE064Q37762450-D8BAD243-692A-4CDE-847D-2AF06C561FC2Q37821064-B391F4B9-F6E2-4E33-A7A2-FE6F71389149Q37826194-214EF6A6-5E8B-4BED-A708-657F758B9F35Q38608414-8387BFCE-35A4-424C-A643-ECC7A14D0BC8Q38700157-B8885B16-1986-4B02-B6BB-B8E430C50EC9Q38832819-8F345A2B-0BDF-47BF-8941-2560565A574FQ38951812-CC86EAC0-FB80-4E28-B90D-E849401FB59BQ38988535-6B483059-3442-4737-98B4-61F6CCF62C60Q39068608-FAF85905-1F2B-4412-AEF2-53C3EE76F4CFQ40979439-017AB8A1-6BCB-4A3D-A916-4C795D20A5AA
P2860
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
@ast
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
@en
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
@en-gb
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
@nl
type
label
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
@ast
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
@en
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
@en-gb
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
@nl
prefLabel
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
@ast
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
@en
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
@en-gb
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
@nl
P2093
P2860
P921
P356
P1433
P1476
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
@en
P2093
Anke K Schütz
Arndt Hartmann
Birgitt Lennartz
Erik Noetzel
Eva Verjans
Hongqi Lue
Jürgen Bernhagen
Nuran Bektas
P2860
P2888
P356
10.1186/1471-2407-9-230
P407
P50
P577
2009-01-01T00:00:00Z
P5875
P6179
1000141217